Passage Bio (PASG) News Today $0.66 +0.01 (+1.22%) (As of 10:56 AM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Will Passage Bio (NASDAQ:PASG) Spend Its Cash Wisely?December 29 at 11:20 AM | finance.yahoo.comOrbimed Advisors vend pour 138.192$ d'actions de Passage BioDecember 27 at 5:39 AM | fr.investing.comOrbimed Advisors Llc Sells 230,321 Shares of Passage Bio, Inc. (NASDAQ:PASG) StockDecember 27 at 5:05 AM | insidertrades.comPassage Bio, Inc. (NASDAQ:PASG) Major Shareholder Orbimed Advisors Llc Sells 54,181 SharesDecember 12, 2024 | insidertrades.comOrbimed Advisors vend pour 51.988$ d'actions de Passage BioDecember 12, 2024 | fr.investing.comInsider Selling: Passage Bio, Inc. (NASDAQ:PASG) Major Shareholder Sells 20,903 Shares of StockDecember 7, 2024 | insidertrades.comOrbiMed Advisors vend des actions de Passage Bio pour une valeur de 77.338€December 6, 2024 | fr.investing.com2,455,800 Shares in Passage Bio, Inc. (NASDAQ:PASG) Purchased by Erste Asset Management GmbHErste Asset Management GmbH bought a new stake in Passage Bio, Inc. (NASDAQ:PASG - Free Report) in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 2,455,800 shares of the company's stock, valued at approximately $1,718,000. EDecember 4, 2024 | marketbeat.comOptimistic Buy Rating for Passage Bio Driven by Promising PBFT02 Therapy Potential and Accelerated Approval PathwayDecember 3, 2024 | markets.businessinsider.comPassage Bio (NASDAQ:PASG) Stock, Option ChainNovember 30, 2024 | benzinga.comPassage Bio assumed with an Outperform at WedbushNovember 30, 2024 | finance.yahoo.comPassage Bio, Inc. (NASDAQ:PASG) Major Shareholder Lynx1 Capital Management Lp Acquires 29,300 SharesNovember 28, 2024 | insidertrades.comPassage Bio enregistre 284.519 dollars d'achats d'actions par Lynx1 CapitalNovember 28, 2024 | fr.investing.comLe titre de Passage Bio atteint un plus bas de 52 semaines à 0,54 $ face aux défis du marchéNovember 16, 2024 | fr.investing.comTD Cowen Keeps Their Buy Rating on Passage Bio (PASG)November 15, 2024 | markets.businessinsider.comPassage Bio CEO Will Chou to Share Insights at Guggenheim Healthcare Innovation Conference!November 8, 2024 | msn.comPassage Bio to Present at Guggenheim Securities Healthcare Innovation ConferenceNovember 6, 2024 | globenewswire.comPassage Bio présente des avancées dans la thérapie génique pour la démenceOctober 25, 2024 | fr.investing.comPassage Bio delivered preclinical, interim data at ESGCTOctober 25, 2024 | markets.businessinsider.comPassage Bio Presents Preclinical and Interim Clinical Data for PBFT02 in FTD-GRN at the European Society of Gene & Cell Therapy (ESGCT) 31st Annual ConferenceOctober 24, 2024 | globenewswire.comLe titre de Passage Bio atteint un plus bas de 52 semaines à 0,55$ face aux défis du marchéOctober 17, 2024 | fr.investing.comLe cours de l'action Passage Bio atteint un plus bas de 52 semaines à 0,57 $ face aux défis du marchéOctober 7, 2024 | fr.investing.comPassage Bio (NASDAQ:PASG) Stock Quotes, Forecast and News SummaryOctober 5, 2024 | benzinga.comPassage Bio’s CEO to Present at Prestigious Genetic Medicines ConferenceSeptember 25, 2024 | msn.comOrbimed Advisors LLC Adjusts Stake in Passage Bio IncSeptember 25, 2024 | finance.yahoo.comPassage Bio to Present at Chardan’s 8th Annual Genetic Medicines ConferenceSeptember 23, 2024 | finance.yahoo.comPassage Bio to Present at Chardan's 8th Annual Genetic Medicines ConferenceSeptember 23, 2024 | globenewswire.comPassage Bio, Inc. (NASDAQ:PASG) Major Shareholder Orbimed Advisors Llc Sells 25,631 SharesSeptember 19, 2024 | insidertrades.comOrbimed Advisors LLC Reduces Stake in Passage Bio IncSeptember 19, 2024 | finance.yahoo.comOptimistic Buy Rating for Passage Bio as PBFT02 Shows Promising Results and Market PotentialSeptember 18, 2024 | markets.businessinsider.comCanaccord voit un potentiel dans l'action de Passage Bio suite aux données positives de l'essai de phase 1/2September 17, 2024 | fr.investing.comPassage Bio Welcomes Tom Kassberg to Board, Aiming to Strengthen Strategic VisionSeptember 12, 2024 | msn.comPassage Bio nomme un nouveau directeur et accorde des options sur actionsSeptember 11, 2024 | fr.investing.comPassage Bio Welcomes Tom Kassberg to Board of DirectorsSeptember 10, 2024 | globenewswire.comPassage Bio prévoit des coûts de dépréciation de 3,5 à 5,5 millions de dollarsSeptember 9, 2024 | fr.investing.comRodman & Renshaw Initiates Coverage of Passage Bio (PASG) with Buy RecommendationSeptember 4, 2024 | msn.comPassage Bio to Present at H.C. Wainwright 26th Annual Global Investment ConferenceAugust 30, 2024 | globenewswire.comPassage Bio Reports Q2 2024 Financial Results and Business UpdatesAugust 10, 2024 | msn.comPassage Bio Reports Second Quarter 2024 Financial Results and Provides Recent Business HighlightsAugust 8, 2024 | globenewswire.comPassage Bio risque d'être radiée de la cote du Nasdaq en raison du prix de son actionAugust 3, 2024 | fr.investing.comPassage Bio Out-Licenses Rare Disease Programs to GEMMA BiotherapeuticsAugust 3, 2024 | msn.comPassage Bio gains after licensing deal with GEMMA BioAugust 1, 2024 | msn.comPassage Bio Out-licenses Three Pediatric Gene Therapy Programs to GEMMA Biotherapeutics and Enters New Research CollaborationAugust 1, 2024 | globenewswire.comPassage Bio (NASDAQ:PASG) Shares Down 4.3% Passage Bio (NASDAQ:PASG) Stock Price Down 4.3%July 24, 2024 | marketbeat.comExpanding Market and Promising Preclinical Results Bolster Buy Rating for Passage BioJuly 20, 2024 | markets.businessinsider.comPassage Bio Announces Positive Feedback from FDA on Expansion of upliFT-D Trial of PBFT02 to Include FTD-C9orf72 PatientsJuly 16, 2024 | globenewswire.comPassage Bio to Present at Goldman Sachs 45th Annual Global Healthcare ConferenceJune 5, 2024 | globenewswire.comFY2024 Earnings Estimate for Passage Bio, Inc. Issued By Chardan Capital (NASDAQ:PASG)Passage Bio, Inc. (NASDAQ:PASG - Free Report) - Equities research analysts at Chardan Capital raised their FY2024 earnings per share estimates for Passage Bio in a report released on Tuesday, May 28th. Chardan Capital analyst Y. Livshits now anticipates that the company will earn ($1.12) per sharMay 31, 2024 | marketbeat.comPassage Bio Announces Recipient of Third Annual Tachi Yamada Scholarship AwardMay 21, 2024 | globenewswire.comOptimistic Outlook for Passage Bio Amid Clinical and Financial Progress: Maintains Buy RatingMay 15, 2024 | markets.businessinsider.com Get Passage Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for PASG and its competitors with MarketBeat's FREE daily newsletter. Email Address WARNING: “Buffett Indicator” flashing for first time in 50 years (Ad)Warren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indicates the Oracle of Omaha is quietly preparing for a historic market crash. His most reliable crash indicator - the "Buffett indicator" - just flashed red for the first time in 25 years. Take these 4 steps today to protect your retirement NOW PASG Media Mentions By Week PASG Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PASG News Sentiment▼-0.030.59▲Average Medical News Sentiment PASG News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PASG Articles This Week▼41▲PASG Articles Average Week Get Passage Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for PASG and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TCRX News CHRS News ZURA News CRBP News STRO News MGX News TSVT News ELUT News SGMT News ADAP News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PASG) was last updated on 12/30/2024 by MarketBeat.com Staff From Our PartnersGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored3 CENT Crypto to Explode December 16th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored>>>RE: Buy this Stock before Trump Takes Office!To make sure everyone has the opportunity to get in, closes for good at midnight on January 1st, we're lowerin...Behind the Markets | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Passage Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Passage Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
